Dopal


CAS No. : 5707-55-1

5707-55-1
Price and Availability of CAS No. : 5707-55-1
Size Price Stock
65.72 mM * 1  mL in Methanol $260 In-stock
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-121252
M.Wt: 152.15
Formula: C8H8O3
Purity: >98 %
Solubility:
Introduction of 5707-55-1 :

Dopal is a metabolite and aldehyde neurotoxin of Dopamine (HY-B0451). Dopal exhibits cytotoxicity, induces α-synuclein oligomerization and aggregation, and is closely associated with the pathogenesis of Parkinson's disease. Dopal can be used in research related to Parkinson's disease[1][2].\n


In Vitro:Dopal (1.5-1500 μM; 0-4 h) induces dose- and time-dependent aggregation of purified human recombinant α-synuclein in a cell-free system; aggregation initiates at concentrations as low as 1.5 μM, and large polymeric α-synuclein aggregates form at concentrations of 300 μM and above[1].
Dopal (3 μM-1 mM; 2-8 h) induces dose-dependent α-synuclein aggregation and cytotoxicity in SHSY-5Y cells overexpressing wild-type α-synuclein, with significant aggregation observed at concentrations ≥30 μM, oligomer formation initiated at 3 μM, and rapid cell death occurring at 1 mM[1].
Dopal (100-150 μM; 18-24 h) exhibits toxicity to SH-SY5Y cells and also induces cell apoptosis[2].
Dopal (100-200 μM; 16-24 h) induces the formation of α-synuclein-EGFP dimers in SH-SY5Y cells overexpressing α-synuclein-EGFP[2]. In Vivo:Dopal (0.2-1.0 μg; stereotaxically injected into the substantia nigra; single dose) induces dose-dependent α-synuclein oligomer formation and causes loss of immunoreactivity for dopaminergic neuron markers in male Parkinson's disease rats[1].

Your information is safe with us.